ARN19702

Research use only, not for human use.

ARN19702 is a selective, orally active, reversible, and brain-penetrant N-acylethanolamine acid amidase (NAAA) inhibitor with an IC50 of 230 nM for human NAAA. ARN19702 has pain relief effects.

ARN19702 is a selective, orally active, reversible, and brain-penetrant N-acylethanolamine acid amidase (NAAA) inhibitor with an IC50 of 230 nM for human NAAA. ARN19702 has pain relief effects.(In Vivo):In male mice, administration of ARN19702 (3-10 mg/kg; p.o.) daily for 7 consecutive days decreases nociception associated with Paclitaxel-induced neuropathy without the development of subacute antinociceptive tolerance. Administration of ARN19702 (0.1-30 mg/kg; p.o.) attenuates dose-dependently the spontaneous nocifensive response elicited by intraplantar formalin injection and the hypersensitivity caused by intraplantar carrageenan injection, paw incision, or sciatic nerve ligation. Administration of ARN19702 (3-10 mg/kg; p.o.) also produces remarkable protective effects against multiple sclerosis in mice.

——

ARN19702 (3-10 mg/kg; po; daily; for 7 consecutive days) reduces nociception associated with Paclitaxel-induced neuropathy without development of subacute antinociceptive tolerance in male rats. In male mice, ARN19702 (0.1-30 mg/kg; po) attenuates in a dose-dependent manner the spontaneous nocifensive response elicited by intraplantar formalin injection and the hypersensitivity caused by intraplantar carrageenan injection, paw incision, or sciatic nerve ligation.. ARN19702 (3-10 mg/kg; po) produces remarkable protective effects against multiple sclerosis in mice.

——

Others

Other Targets

DHODH

——

——

1971937-18-4

447.54

C21H22FN3O3S2

>98% (HPLC)

——

CCS(=O)(=O)c1ccccc1C(=O)N1CCN(C[C@@H]1C)c1nc2ccc(F)cc2s1

——

(-20℃)

With Ice Pack

≥ 2 years